Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Satoru Muto

Showing results (61-70 of 127) with videos related to

Pageof 13
Sort By:
The Prostate|February 1, 2012
Testosterone promotes DNA damage response under oxidative stress in prostate cancer cell linesHisamitsu Ide, Yan Lu, Jingsong Yu, et al.
Prostate International|October 18, 2014
Circulating tumor cell count during zoledronic acid treatment in men with metastatic prostate cancer: a pilot studyHisamitsu Ide, Yan Lu, Toshiaki Tanaka, et al.
Clinical and Experimental Nephrology|February 10, 2015
The effect of tolvaptan on autosomal dominant polycystic kidney disease patients: a subgroup analysis of the Japanese patient subset from TEMPO 3:4 trialSatoru Muto, Haruna Kawano, Eiji Higashihara, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|March 22, 2014
Usefulness of proton magnetic resonance spectroscopy in predicting positive biopsy after high-intensity focused ultrasound for treatment of localized prostate cancerSatoru Muto, Tatsuro Kaminaga, Akira Horiuchi, et al.
Anticancer Research|July 18, 2008
Clinical efficacy of proton magnetic resonance spectroscopy (1H-MRS) in the diagnosis of localized prostate cancerKeisuke Saito, Tatsuro Kaminaga, Satoru Muto, et al.
Japanese Journal of Clinical Oncology|April 28, 2010
Novel germ line mutation p53-P177R in adult adrenocortical carcinoma producing neuron-specific enolase as a possible markerHisamitsu Ide, Yuichi Terado, Shino Tokiwa, et al.
Prostate International|November 14, 2013
Serum level of follicle-stimulating hormone is associated with extraprostatic extension of prostate cancerHisamitsu Ide, Yuichi Terado, Kentaro Sakamaki, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|March 11, 2017
Effectiveness of platinum-based adjuvant chemotherapy for muscle-invasive bladder cancer: A weighted propensity score analysisFumitaka Shimizu, Satoru Muto, Masataka Taguri, et al.
Korean Journal of Urology|June 29, 2012
Clinical Usefulness of Corticotropin Releasing Hormone Testing in Subclinical Cushing's Syndrome for Predicting Cortisol Replacement after AdrenalectomyMasahiro Inoue, Hisamitsu Ide, Koji Kurihara, et al.
The Journal of Sexual Medicine|April 22, 2008
Salivary 8-OHdG: a useful biomarker for predicting severe ED and hypogonadismMitsuko Yasuda, Hisamitsu Ide, Kumiko Furuya, et al.
Pageof 13

Showing results (61-70 of 127) with videos related to

Sort By:
Pageof 13
The Prostate|February 1, 2012
Testosterone promotes DNA damage response under oxidative stress in prostate cancer cell linesHisamitsu Ide, Yan Lu, Jingsong Yu, et al.
Prostate International|October 18, 2014
Circulating tumor cell count during zoledronic acid treatment in men with metastatic prostate cancer: a pilot studyHisamitsu Ide, Yan Lu, Toshiaki Tanaka, et al.
Clinical and Experimental Nephrology|February 10, 2015
The effect of tolvaptan on autosomal dominant polycystic kidney disease patients: a subgroup analysis of the Japanese patient subset from TEMPO 3:4 trialSatoru Muto, Haruna Kawano, Eiji Higashihara, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|March 22, 2014
Usefulness of proton magnetic resonance spectroscopy in predicting positive biopsy after high-intensity focused ultrasound for treatment of localized prostate cancerSatoru Muto, Tatsuro Kaminaga, Akira Horiuchi, et al.
Anticancer Research|July 18, 2008
Clinical efficacy of proton magnetic resonance spectroscopy (1H-MRS) in the diagnosis of localized prostate cancerKeisuke Saito, Tatsuro Kaminaga, Satoru Muto, et al.
Japanese Journal of Clinical Oncology|April 28, 2010
Novel germ line mutation p53-P177R in adult adrenocortical carcinoma producing neuron-specific enolase as a possible markerHisamitsu Ide, Yuichi Terado, Shino Tokiwa, et al.
Prostate International|November 14, 2013
Serum level of follicle-stimulating hormone is associated with extraprostatic extension of prostate cancerHisamitsu Ide, Yuichi Terado, Kentaro Sakamaki, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|March 11, 2017
Effectiveness of platinum-based adjuvant chemotherapy for muscle-invasive bladder cancer: A weighted propensity score analysisFumitaka Shimizu, Satoru Muto, Masataka Taguri, et al.
Korean Journal of Urology|June 29, 2012
Clinical Usefulness of Corticotropin Releasing Hormone Testing in Subclinical Cushing's Syndrome for Predicting Cortisol Replacement after AdrenalectomyMasahiro Inoue, Hisamitsu Ide, Koji Kurihara, et al.
The Journal of Sexual Medicine|April 22, 2008
Salivary 8-OHdG: a useful biomarker for predicting severe ED and hypogonadismMitsuko Yasuda, Hisamitsu Ide, Kumiko Furuya, et al.
Pageof 13